UNSPSC 51241516: Chlorobutanol/edta/polyvinyl alcohol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241516 Chlorobutanol/edta/polyvinyl alcohol is a Commodity code covering specialized pharmaceutical excipients and preservative compounds used in ophthalmic and injectable formulations. State and local government procurement under this code focuses on bulk pharmaceutical raw materials and finished products meeting FDA cGMP standards and Drug Supply Chain Security Act compliance, sourced through authorized pharmaceutical wholesalers for distribution across government healthcare facilities. Issuing bodies are primarily state health departments and multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions to achieve volume-based pricing and standardized supply agreements.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of Procurement, is the primary recent buyer, having issued RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and over-the-counter products with response due March 26, 2026. The MMCAP contract spans Minnesota and Oregon and requires vendors to supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with all products available by May 15, 2026 for an effective date of July 1, 2026. Awarded vendors must maintain cGMP and DSCSA certification, hold contractual relationships with at least two of the three wholesalers, and comply with a 3 percent administrative fee on all purchases; evaluation will weight price competitiveness at 75 percent, with the remaining 25 percent split across fixed pricing, administrative format compliance, EDI capability, and fee acceptance. The contract term is two years for new responders with optional extensions, and the RFP does not identify specific set-aside or disadvantaged-enterprise restrictions.